Literature DB >> 22076450

Sporadic CNS hemangioblastomatosis, response to sunitinib and secondary polycythemia.

German Reyes-Botero, Jaime Gállego Pérez-Larraya, Jaime Gallego Pérez-Larraya, Marc Sanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22076450     DOI： 10.1007/s11060-011-0752-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


× No keyword cloud information.
  7 in total

1.  Spinal leptomeningeal hemangioblastomatosis in von Hippel-Lindau disease: magnetic resonance and pathological findings.

Authors:  R Bakshi; L L Mechtler; M J Patel; B D Lindsay; S Messinger; K J Gibbons
Journal:  J Neuroimaging       Date:  1997-10       Impact factor: 2.486

2.  Paradoxical secondary polycythemia in von Hippel-Lindau patients treated with anti-vascular endothelial growth factor receptor therapy.

Authors:  Stéphane Richard; Laure Croisille; Jeannine Yvart; Nicole Casadeval; Pascal Eschwège; Nozar Aghakhani; Philippe David; Alain Gaudric; Paul Scigalla; Olivier Hermine
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

3.  Clinical and molecular analysis of disseminated hemangioblastomatosis of the central nervous system in patients without von Hippel-Lindau disease. Report of four cases.

Authors:  Robert J Weil; Alexander O Vortmeyer; Zhengping Zhuang; Svetlana D Pack; Nicholas Theodore; Robert K Erickson; Edward H Oldfield
Journal:  J Neurosurg       Date:  2002-04       Impact factor: 5.115

4.  Intradural extramedullary leptomeningeal hemangioblastomatosis and paraneoplastic limbic encephalitis diagnosed at autopsy: an unlikely pair.

Authors:  Rageshree Ramachandran; Han Sung Lee; Brandy Matthews; Alan Shatzel; Tarik Tihan
Journal:  Arch Pathol Lab Med       Date:  2008-01       Impact factor: 5.534

5.  Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report.

Authors:  Lisa R Rogers; Patricia LoRusso; Paul Nadler; Ghaus Malik; Anthony Shields; William Kaelin
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

6.  Long-term use of intravitreal bevacizumab (avastin) for the treatment of von hippel-lindau associated retinal hemangioblastomas.

Authors:  Frank N Hrisomalos; Raj K Maturi; Veena Pata
Journal:  Open Ophthalmol J       Date:  2010-10-21

Review 7.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088
  7 in total
  3 in total

1.  Disseminated cerebellar hemangioblastoma in two patients without von Hippel-Lindau disease.

Authors:  Jiro Akimoto; Hirokazu Fukuhara; Tomohiro Suda; Kenta Nagai; Ryo Hashimoto; Kohno Michihiro
Journal:  Surg Neurol Int       Date:  2014-10-07

Review 2.  Sporadic supratentorial hemangioblastoma with meningeal affection: A case report and literature review.

Authors:  Juan Francisco Sánchez-Ortega; Marta Claramonte; Mónica Martín; Juan Calatayud-Pérez
Journal:  Surg Neurol Int       Date:  2021-08-09

3.  Aggressive dissemination of central nervous system hemangioblastoma without association with von Hippel-Lindau disease: A case report and literature review.

Authors:  François Dantas; Jair Leopoldo Raso; Patrícia Salomé Gouvea Braga; Ricardo Vieira Botelho; Fernando Luiz Rolemberg Dantas
Journal:  Surg Neurol Int       Date:  2022-08-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.